Intragastric Balloon Market 2018: Study on Eminent Players | Allurion Technologies, Silimed, Districlass Medical, Obalon Therapeutics, ReShape Medical, Lexel, Medsil, Apollo Endosurgery, Spatz, Life Partners Europe and Helioscopie Medical Implants
Intragastric Balloon Market size was around USD 120 million in 2015, growing at over 9.5% CAGR from 2016 to 2024.
(EMAILWIRE.COM, August 11, 2018 ) Intragastric Balloons Market is slated to exceed USD 270 million by 2024, as per a new research report.
High prevalence of obesity due to improper lifestyle and food choices is the predominant factor resulting to increasing demand of intragastric balloons, therefore driving the market growth. Increasing efforts for early diagnosis of obesity should add on to demand in years to come.
Extensive use of intragastric balloons due to its affordability over other intensive surgeries will further augment adoption rates over the forecast timeframe. Moreover, being a minimally invasive solution, the popularity of intragastric balloons is proliferating rapidly around the world.
Shorter hospital admission time for intragastric balloons procedure than surgery hospital admission time is also a decisive factor for patient to choose balloons over surgery this also contributes to demand for intragastric balloon.
From the industry side, technological innovation along with treatment associated reduced costs and effective non-surgical treatment evolving from high regulatory approval rates of intragastric balloons procedure are some of the high impact rendering forces that are driving the market growth.
Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/1173
Despite of several advantages of intragastric balloons, harmful effects such as probability of damage to esophagus due to erosion and persistent nausea and vomiting caused by intragastric balloons are most likely to hamper the market growth over the forecast timeframe.
Growing awareness coupled with increasing acceptance of minimal invasive procedures spurred the single intragastric balloons market growth by the end of 2016, more than 50% of global market value was attributed by single intragastric balloons sales. High effectiveness and efficiency to detect deflation due to methylene blue of saline filled balloons should propel its market growth during the forecast period.
Presence of high number of skilled personnel, preference of patients towards hospitals over other healthcare settings and higher funding in hospital industry resulted to highest market share of hospitals among all end users in intragastric balloons market. However, increasing popularity of clinics among the patients because of individual patient centric healthcare offering should drive the clinics’ end user market faster than traditional healthcare settings market.
Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/1173
U.S. intragastric balloons market is strongly driven by favorable government initiatives and high awareness among the patients. In coming years, rapidly escalating rate of obesity will most likely give rise to the risk of type-II diabetes, gall bladder and other related diseases, resulting to demand for intragastric balloons.
Germany intragastic balloons market is forecasted to grow over 10% CAGR during the forecast period. Rising rate of obesity, growing demand for weight reduction procedures coupled with high awareness should drive the market growth.
China intragastric balloons market is poised to witness high growth in coming five-seven years, owing to improving and expanding healthcare facilities, growing awareness about drawbacks of obesity and use of intragastric balloons to prevent the same.
Allurion Technologies, Apollo Endosurgery, Districlass Medical SA, Endalis, Helioscopie Medical Implants, Lexel Srl, Life Partners Europe, Medicone, Medsil, ReShape Medical Inc, Silimed Inc are some of the major companies operating the market.
High prevalence of obesity due to improper lifestyle and food choices is the predominant factor resulting to increasing demand of intragastric balloons, therefore driving the market growth. Increasing efforts for early diagnosis of obesity should add on to demand in years to come.
Extensive use of intragastric balloons due to its affordability over other intensive surgeries will further augment adoption rates over the forecast timeframe. Moreover, being a minimally invasive solution, the popularity of intragastric balloons is proliferating rapidly around the world.
Shorter hospital admission time for intragastric balloons procedure than surgery hospital admission time is also a decisive factor for patient to choose balloons over surgery this also contributes to demand for intragastric balloon.
From the industry side, technological innovation along with treatment associated reduced costs and effective non-surgical treatment evolving from high regulatory approval rates of intragastric balloons procedure are some of the high impact rendering forces that are driving the market growth.
Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/1173
Despite of several advantages of intragastric balloons, harmful effects such as probability of damage to esophagus due to erosion and persistent nausea and vomiting caused by intragastric balloons are most likely to hamper the market growth over the forecast timeframe.
Growing awareness coupled with increasing acceptance of minimal invasive procedures spurred the single intragastric balloons market growth by the end of 2016, more than 50% of global market value was attributed by single intragastric balloons sales. High effectiveness and efficiency to detect deflation due to methylene blue of saline filled balloons should propel its market growth during the forecast period.
Presence of high number of skilled personnel, preference of patients towards hospitals over other healthcare settings and higher funding in hospital industry resulted to highest market share of hospitals among all end users in intragastric balloons market. However, increasing popularity of clinics among the patients because of individual patient centric healthcare offering should drive the clinics’ end user market faster than traditional healthcare settings market.
Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/1173
U.S. intragastric balloons market is strongly driven by favorable government initiatives and high awareness among the patients. In coming years, rapidly escalating rate of obesity will most likely give rise to the risk of type-II diabetes, gall bladder and other related diseases, resulting to demand for intragastric balloons.
Germany intragastic balloons market is forecasted to grow over 10% CAGR during the forecast period. Rising rate of obesity, growing demand for weight reduction procedures coupled with high awareness should drive the market growth.
China intragastric balloons market is poised to witness high growth in coming five-seven years, owing to improving and expanding healthcare facilities, growing awareness about drawbacks of obesity and use of intragastric balloons to prevent the same.
Allurion Technologies, Apollo Endosurgery, Districlass Medical SA, Endalis, Helioscopie Medical Implants, Lexel Srl, Life Partners Europe, Medicone, Medsil, ReShape Medical Inc, Silimed Inc are some of the major companies operating the market.
Contact Information:
Global Market Insights, Inc.
Arun Hegde
Tel: 1-888-689-0688
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Global Market Insights, Inc.
Arun Hegde
Tel: 1-888-689-0688
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results